9 research outputs found
Role of chondroitin sulfate proteoglycans (CSPGs) in synaptic plasticity and neurotransmission in mammalian spinal cord.
Chronic unilateral hemisection (HX) of the adult rat spinal cord diminishes conduction through intact fibers in the ventrolateral funiculus (VLF) contralateral to HX. Intraspinal injections of Chondroitinase-ABC, known to digest chondroitin sulfate proteoglycans (CSPGs) in the vicinity of injury, prevented this decline of axonal conduction. This was associated with improved locomotor function. We further injected three purified CSPGs into the lateral column of the uninjured cord at T10: NG2 and neurocan, which increase in the vicinity of a spinal injury, and aggrecan, which decreases. Intraspinal injection of NG2 acutely depressed axonal conduction through the injection region in a dose dependent manner. Similar injections of saline, aggrecan, or neurocan had no significant effect. These results identify a novel acute action of CSPGs on axonal conduction in spinal cord, and suggest that antagonism of proteoglycans reverses or prevents the decline of axonal conduction, in addition to stimulating axonal growth
Alterations of action potentials and the localization of Nav1.6 sodium channels in spared axons after hemisection injury of the spinal cord in adult rats
Previously, we reported a pronounced reduction in transmission through surviving axons contralateral to chronic hemisection (HX) of adult rat spinal cord. To examine the cellular and molecular mechanisms responsible for this diminished transmission, we recorded intracellularly from lumbar lateral white matter axons in deeply anesthetized adult rats in vivo and measured the propagation of action potentials (APs) through rubrospinal/reticulospinal tract (RST/RtST) axons contralateral to chronic HX at T10. We found decreased excitability in these axons, manifested by an increased rheobase to trigger APs and longer latency for AP propagation passing the injury level, without significant differences in axonal resting membrane potential and input resistance. These electrophysiological changes were associated with altered spatial localization of Nav1.6 sodium channels along axons: a subset of axons contralateral to the injury exhibited a diffuse localization (>10 ÎŒm spread) of Nav1.6 channels, a pattern characteristic of demyelinated axons (Craner MJ, Newcombe J, Black JA, Hartle C, Cuzner ML, Waxman SG. Proc Natl Acad Sci USA 101: 8168â8173, 2004b). This result was substantiated by ultrastructural changes seen with electron microscopy, in which an increased number of large-caliber, demyelinated RST axons were found contralateral to the chronic HX. Therefore, an increased rheobase, pathological changes in the distribution of Nav1.6 sodium channels, and the demyelination of contralateral RST axons are likely responsible for their decreased conduction chronically after HX and thus may provide novel targets for strategies to improve function following incomplete spinal cord injury
Recommended from our members
Combined delivery of Nogo-A antibody, neurotrophin-3 and the NMDA-NR2d subunit establishes a functional 'detour' in the hemisected spinal cord.
To encourage re-establishment of functional innervation of ipsilateral lumbar motoneurons by descending fibers after an intervening lateral thoracic (T10) hemisection (Hx), we treated adult rats with the following agents: (i) anti-Nogo-A antibodies to neutralize the growth-inhibitor Nogo-A; (ii) neurotrophin-3 (NT-3) via engineered fibroblasts to promote neuron survival and plasticity; and (iii) the NMDA-receptor 2d (NR2d) subunit via an HSV-1 amplicon vector to elevate NMDA receptor function by reversing the Mg(2+) block, thereby enhancing synaptic plasticity and promoting the effects of NT-3. Synaptic responses evoked by stimulation of the ventrolateral funiculus ipsilateral and rostral to the Hx were recorded intracellularly from ipsilateral lumbar motoneurons. In uninjured adult rats short-latency (1.7-ms) monosynaptic responses were observed. After Hx these monosynaptic responses were abolished. In the Nogo-Abâ+âNT-3â+âNR2d group, long-latency (approximately 10âms), probably polysynaptic, responses were recorded and these were not abolished by re-transection of the spinal cord through the Hx area. This suggests that these novel responses resulted from new connections established around the Hx. Anterograde anatomical tracing from the cervical grey matter ipsilateral to the Hx revealed increased numbers of axons re-crossing the midline below the lesion in the Nogo-Abâ+âNT-3â+âNR2d group. The combined treatment resulted in slightly better motor function in the absence of adverse effects (e.g. pain). Together, these results suggest that the combination treatment with Nogo-Abâ+âNT-3â+âNR2d can produce a functional 'detour' around the lesion in a laterally hemisected spinal cord. This novel combination treatment may help to improve function of the damaged spinal cord
Cardiac phenotype in ATP1A3-related syndromes A multicenter cohort study
Objective
To define the risks and consequences of cardiac abnormalities in
ATP1A3-related syndromes.
Methods
Patients meeting clinical diagnostic criteria for rapid-onset
dystonia-parkinsonism (RDP), alternating hemiplegia of childhood (AHC),
and cerebellar ataxia, areflexia, pes cavus, optic atrophy, and
sensorineural hearing loss (CAPOS) with ATP1A3 genetic analysis and at
least 1 cardiac assessment were included. We evaluated the cardiac
phenotype in an Atp1a3 knock-in mouse (Mashl(+/-)) to determine the
sequence of events in seizure-related cardiac death.
Results
Ninety-eight patients with AHC, 9 with RDP, and 3 with CAPOS (63 female,
mean age 17 years) were included. Resting ECG abnormalities were found
in 52 of 87 (60%) with AHC, 2 of 3 (67%) with CAPOS, and 6 of 9 (67%)
with RDP. Serial ECGs showed dynamic changes in 10 of 18 patients with
AHC. The first Holter ECG was abnormal in 24 of 65 (37%) cases with AHC
and RDP with either repolarization or conduction abnormalities.
Echocardiography was normal. Cardiac intervention was required in 3 of
98 (approximate to 3%) patients with AHC. In the mouse model, resting
ECGs showed intracardiac conduction delay; during induced seizures,
heart block or complete sinus arrest led to death.
Conclusions
We found increased prevalence of ECG dynamic abnormalities in all
ATP1A3-related syndromes, with a risk of life-threatening cardiac rhythm
abnormalities equivalent to that in established cardiac channelopathies
(approximate to 3%). Sudden cardiac death due to conduction abnormality
emerged as a seizure-related outcome in murine Atp1a3-related disease.
ATP1A3-related syndromes are cardiac diseases and neurologic diseases.
We provide guidance to identify patients potentially at higher risk of
sudden cardiac death who may benefit from insertion of a pacemaker or
implantable cardioverter-defibrillator